Jinguan Lin

机构：Central South University, Hunan Cancer Hospital, Chemotherapy Foundation

发表论文 60 篇 · 总被引 3694 次 · h-index 27

代表论文

• Endoplasmic reticulum stress—a key guardian in cancer (2024 · Cell Death Discovery · 被引 167)
• Altered glycosylation in cancer: molecular functions and therapeutic potential (2024 · 癌症：英文版 · 被引 112)
• Cellular metabolism: A key player in cancer ferroptosis (2024 · 癌症：英文版 · 被引 60)
• Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation (2024 · Molecular Cancer · 被引 40)
• CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance (2025 · Molecular Cancer · 被引 30)
• Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial (2025 · Journal of Hematology & Oncology · 被引 27)